Skip to main navigation Skip to search Skip to main content

L-Glutamate binding sites of normal and atrophic human cerebellum

  • P. Tsiotos
  • , A. Plaitakis
  • , A. Mitsacos
  • , G. Voukelatou
  • , M. Michalodimitrakis
  • , E. D. Kouvelas

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

The binding kinetics, pharmacologic properties, ontogeny and localization of L-glutamate binding sites were studied in membrane preparations and sections of normal and olivopontocerebellar atrophy (OPCA) human cerebellum. One binding component was found with a Kd value in the order of 150 × 10-9 M. No significant changes of Kd values were observed with age, whereas the highest Bmax value was observed at the age of 1 year. L-Aspartate, ibotenate, quisqualate and L-homocysteic acid were potent inhibitors of L-[3H]glutamate binding. Quantitative densitometric measuremenst indicated the presence of l-glutamate sites in both the molecular and granule cell layer. In OPCA cerebella a very significant decrease of L-[3H]glutamate specific binding (Bmax was observed, whereas Kd values were found unchanged. The pharmacologic properties of L-[3H]glutamate binding sites of OPCA cerebellar tissues were similar to those of normal cerebellum. [3H]quinuclidinyl benzylate binding, expressed in fmol/mg protein, did not show significant differences between normal and OPCA cerebella.

Original languageEnglish
Pages (from-to)87-96
Number of pages10
JournalBrain Research
Volume481
Issue number1
DOIs
StatePublished - 27 Feb 1989
Externally publishedYes

Keywords

  • Development
  • Human cerebellum
  • L-Glutamate binding
  • Localization
  • Olivopontocerebellar atrophy
  • Pharmacology

Fingerprint

Dive into the research topics of 'L-Glutamate binding sites of normal and atrophic human cerebellum'. Together they form a unique fingerprint.

Cite this